SJS, Lupus, APS, VWF, and Adrenal Insufficiency: A Convergence of Multisystem Disorders with Overlapping Risk

This research in progress documents the case of a woman over 70 who suffered serious harm due to medical neglect and the administration of toxic treatments by healthcare providers.

Introduction

Multisystem diseases such as Stevens-Johnson Syndrome (SJS)Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), and von Willebrand Factor (VWF) disorders can present with overlapping involvement of the skin, heart, blood vessels, immune system, HPA axis/endocrine system. Adrenal insufficiency, often overlooked in critically ill patients, may also be a life-threatening complication, especially in the setting of systemic inflammation or steroid withdrawal. This article explores their interrelation, highlighted by a case of phenytoin-induced fatal hypersensitivity reaction.

HLA-B*5801 Drug interactions cause SJS, rs3095318(A;T)

HLA-B*5801 allele and allopurinol side effects see discussion at rs3095318

CDSN PSORS1C1

The minor allele rs3095318(T), as defined on the minus strand, is reported to be associated in Japanese populations with the HLA-B*5801 allele and therefore susceptibility to severe side effects from taking allopurinol and perhaps other drugs. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.
Reference: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC https://pubmed.ncbi.nlm.nih.gov/16998491/

Allopurinol can cause severe side effects, including life-threatening skin reactions (Stevens-Johnson Syndrome/TEN) and Allopurinol Hypersensitivity Syndrome (AHS/DRESS) with fever, rash, liver/kidney issues, and swollen glands, often in the first weeks or months. Drug interactions with medications like warfarin, azathioprine, or ampicillin can increase risks, especially with poor kidney function, necessitating immediate medical attention for symptoms like yellowing skin, severe rash, extreme fatigue, unusual bleeding, or difficulty breathing.
References: https://www.snpedia.com/index.php/rs1801131

Allopurinol can cause severe reactions:

Especially: Allopurinol Hypersensitivity Syndrome (AHS) and severe skin reactions like Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), marked by fever, rash, blisters, jaundice, and organ issues (kidney, liver). Other serious effects include blood disorders, kidney damage, and severe allergic reactions. Drug interactions, like with warfarin, azathioprine, thiopurines, or ampicillin, can increase risks, necessitating immediate medical help for symptoms like difficulty breathing, severe rash, unusual bleeding, or yellowing skin/eyes
References: https://www.ncbi.nlm.nih.gov/books/NBK548098/#:~:text=Chronic%20therapy%20with%20allopurinol%20is%20associated%20with,systemic%20symptoms%20%E2%80%94%20DRESS%20syndrome)%20(Case%201).

Other names for allopurinol?

Allopurinol is a generic drug sold under a variety of brand names, including Allohexal, Allosig, Milurit, Alloril, Progout, Ürikoliz, Zyloprim, Zyloric, Zyrik, and Aluron.


1. Stevens-Johnson Syndrome (SJS)Mucocutaneous Hypersensitivity Reaction

Overview

SJS is a rare, immune-mediated skin and mucosal disorder, typically triggered by drugs such as:

  • Antiepileptics (phenytoin, carbamazepine)

  • Antibiotics

  • Allopurinol, NSAIDs

    Warfarin (German: Coumadin or Marcumar) - induced Stevens-Johnson syndrome with severe liver injury https://pubmed.ncbi.nlm.nih.gov/34311601/

    Gabapentin Cases of severe skin rashes, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported. https://pubmed.ncbi.nlm.nih.gov/26321400/

Clinical Features

  • Widespread skin pain and epidermal detachment

  • Mucosal erosions (ocular, oral, genital)

  • Fever, systemic inflammation

  • Onset: 1–3 weeks after drug initiation

    Severity: High ferritin levels are associated with a worse prognosis in SJS, according to NIH. A ferritin level over
    10,000 ng/mL10 comma 000 ng/mL
    is highly suggestive of HLH, which can occur in conjunction with SJS

    Rare vardenafil-associated Stevens-Johnson syndrome: toxic epidermal necrolysis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8886404/


2. MyocarditisCardiac Inflammation

Causes

  • Infection (e.g., viral)

  • Autoimmune diseases (e.g., lupus)

  • Drug hypersensitivity (as seen with phenytoin)

Symptoms

  • Chest pain, palpitations

  • Hypotension, arrhythmias

  • Heart failure and sudden cardiac arrest

Diagnosis

  • Elevated troponins/BNP

  • Cardiac MRI

  • Biopsy if feasible


3. Lupus (SLE)Autoimmune Multisystem Disease

Systemic Involvement

  • Skin (malar rash), joints, kidneys, eyes

  • Hematologic: Anemia, thrombocytopenia

  • Cardiac: Pericarditis, myocarditis

  • Endocrine: Possible adrenal involvement (secondary AI)

Overlap with APS and VWF dysfunction


4. Antiphospholipid Syndrome (APS)Prothrombotic Autoimmune State

Key Features

    • Recurrent venous/arterial thrombosis

    • Coexists with lupus in ~40% of cases
    • Cardiac complications

    • Brain inflammation 
  • APS (Antiphospholipid Syndrome) causes brain inflammation and damage through both blood clots (thrombosis) leading to strokes/ischemia, and direct immune attacks, where autoantibodies disrupt the blood-brain barrier, causing inflammation, cytokine release, and neuronal damage, resulting in symptoms like stroke, headaches, cognitive issues, seizures, and movement disorders. It's a dual process involving clotting and immune-mediated inflammation that damages brain tissue and function.
    Reference:
    Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8200381/

    APS (Antiphospholipid Syndrome) encephalitis involves brain inflammation (encephalitis) caused by autoantibodies attacking the brain, leading to cognitive issues, seizures, movement disorders, and memory loss, often presenting as "brain fog," and requires immunosuppressive treatments like steroids or IVIG, distinct from typical viral causes but sharing inflammatory mechanisms with other autoimmune encephalitides.
    Reference: 
    Encephalitis
    https://www.mayoclinic.org/diseases-conditions/encephalitis/symptoms-causes/syc-20356136#:~:text=Encephalitis%20(en%2Dsef%2Duh,such%20as%20mosquitos%20and%20ticks


5. von Willebrand Factor (VWF) Types 2 and 5Hemostatic Dysfunction

VWF Type 2

  • Qualitative defect → dysfunctional VWF

  • Mucosal bleeding risk, platelet adhesion issues

VWF Type 5

  • Rare, variant type—combined secretion and function defect

  • May appear in autoimmune or inflammatory states (e.g., lupus)

  • Possible link to paradoxical bleeding or thrombosis


6. Adrenal Insufficiency (AI)Endocrine Failure in Critical Illness

Definition

AI occurs when the adrenal glands fail to produce adequate cortisol, critical for stress response, blood pressure regulation, and immune modulation.

Types

  • Primary AI: Adrenal destruction (e.g., Addison’s disease)

  • Secondary AI: Pituitary dysfunction or long-term steroid use

  • Acute AI in critical illness: May be triggered by:

    • Severe inflammation (e.g., SJS/DRESS)

    • Hemodynamic instability

    • Abrupt withdrawal of corticosteroids

Clinical Signs

  • Hypotension unresponsive to fluids/inotropes

  • Hyponatremia, hyperkalemia

  • Fatigue, confusion, vomiting

  • Shock

Relevance in This Case

In the context of SJS and myocarditis, AI should be suspected if hypotension persists despite inotropes. Cortisol deficiency exacerbates cardiovascular collapse and contributes to multi-organ failure.


7. Case Report: Fatal Phenytoin-Induced SJS, and Suspected Adrenal Crisis

Patient Presentation

  • Started on phenytoin (Zentropil) for seizures

  • Developed fever, mucosal erosions, rash, hypotension

  • Labs: Normal LFTs, APTT 32s, platelets 143,000/mm³

  • GCS 4/15, ventilator-dependent, renal dysfunction

Management

  • Inotropes, IV hydrocortisone 100 mg (possibly for adrenal support)

  • Phenytoin discontinued, switched to sodium valproate

  • Despite support, suffered two cardiac arrests; died within 18 hours

Suspected Adrenal Involvement

  • Persistent hypotension despite fluids and vasopressors

  • High stress state without endogenous cortisol compensation

  • Adrenal insufficiency likely contributed to poor outcome

8


Condition

Cardiac Involvement

Skin Involvement

Coagulation Effects

Endocrine Impact

Medication-Triggered

Stevens–Johnson Syndrome (SJS)

Rare (secondary stress effects)

Severe mucocutaneous necrosis

Mucosal bleeding risk

Cortisol depletion due to extreme stress

Yes

Myocarditis or
Heart rhythm issues

Primary involvement

None

Possible thrombosis due to inflammation

Secondary adrenal dysfunction in shock

Yes

Systemic Lupus Erythematosus (SLE)

Common (pericarditis, myocarditis)

Common

Bleeding and/or thrombosis

Possible secondary adrenal insufficiency

No

Antiphospholipid Syndrome (APS)

Common (ischemia, valve disease)

Rare

Predominantly thrombotic

May overlap with adrenal insufficiency

No

von Willebrand Factor Disorder (Type 2/5)

None

Mucosal bleeding

Bleeding ± paradoxical clotting

None

No







9. Conclusion

This case highlights the complex interplay between drug hypersensitivity, autoimmune dysfunction, hemostatic imbalance, and endocrine failure:

  • Phenytoin-induced hypersensitivity can cause both SJS and myocarditis, with possible adrenal suppression.

  • APS and lupus increase the risk of cardiac, vascular, and coagulopathic complications

  • VWF type 2 or 5 abnormalities can worsen bleeding in mucosal or inflammatory lesions

  • Adrenal insufficiency should be considered early in critically ill patients with persistent hypotension, particularly in immune-mediated syndromes.

Until now, we do not fully understand how certain medications provoke such severe multi-organ toxicity. Immune genetics, endothelial injury, hormonal axis disruption, and coagulation system anomalies all contribute.

Food and Drugs to avoid by APS and Lupus

For Antiphospholipid Syndrome (APS) and Lupus, foods to be cautious with include those high in Vitamin K (leafy greens if on warfarin), alfalfa, and potentially garlic, while avoiding excessive alcohol and ultra-processed foods. Medications to watch for include certain birth controls (estrogen-containing), hormone therapy (HRT), some antibiotics, and NSAIDs (like ibuprofen) when on blood thinners like warfarin, as they increase bleeding or clotting risks; always consult your doctor.

The most common trigger for https://pmc.ncbi.nlm.nih.gov/articles/PMC8886404/ is a reaction to certain medications, particularly anticonvulsants, antibiotics, and anti-inflammatory drugs. Other potential triggers include infections, like Mycoplasma pneumoniae, and even certain vaccinations.






Medications:

Anticonvulsants: Lamotrigine, carbamazepine, and phenytoin are frequently implicated.

Antibiotics: Sulfonamides, such as trimethoprim-sulfamethoxazole, are common culprits.

Anti-inflammatory drugs: NSAIDs, especially oxicams, have been linked to SJS.

Other medications: Allopurinol (used for gout), and nevirapine (used for HIV) can also trigger SJS. 

It's important to acknowledge that monoclonal antibodies can cause serious reactions in some individuals. https://my.clevelandclinic.org/health/drugs/19712-rituximab-injection

Infections:

Viral infections like herpes, mumps, and flu have been associated with SJS, particularly in children.

Mycoplasma pneumoniae infection can also trigger the condition.

Other Contributing Factors

Vaccinations, malignancy, systemic inflammatory or autoimmune diseases, and exposure to external chemicals have all been associated with the development of Stevens–Johnson syndrome (SJS).

Genetic susceptibility also plays a role; certain human leukocyte antigen (HLA) types may increase individual risk.


APS-Related Brain Swelling (Thrombo-Inflammatory Edema)

Primary Mechanisms

  • Impaired venous outflow (e.g., cerebral venous thrombosis or diffuse microthrombi)

  • Endothelial activation and dysfunction driven by antiphospholipid antibodies

  • Disruption of the blood–brain barrier (BBB)

  • Development of secondary vasogenic ± cytotoxic edema

  • Resultant elevation of intracranial pressure (ICP) can lead to secondary encephalopathy due to impaired cerebral perfusion and edema.

Key Pathophysiology

  • This is not a true inflammatory vasculitis of the vessel wall

  • Pathology is driven by clot-related venous congestion combined with immune-mediated endothelial activation

  • Commonly occurs in antiphospholipid syndrome (APS), with or without associated lupus

  • Symptoms may worsen with pressure or altitude changes (e.g., air travel)

Neurologic and Visual Effects

  • Raised ICP and venous congestion can impair optic nerve perfusion

  • Transient or persistent vision interruption may occur, including:

    • Blurred or dimmed vision

    • Visual field defects

    • Episodic visual blackouts or “graying out”

  • Visual symptoms may fluctuate with changes in intracranial pressure and cerebral venous flow

Reference:

Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
https://jamanetwork.com/journals/jamadermatology/fullarticle/2841453

Long-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
https://academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljaf380/8265391?login=false

Stevens-Johnson Syndrome After Immunization With Smallpox, Anthrax, and Tetanus Vaccines https://www.mayoclinicproceedings.org/article/S0025-6196(11)62605-0/fulltext

Stevens-Johnson Syndrome https://www.ncbi.nlm.nih.gov/books/NBK459323/

Recurrent Stevens–Johnson syndrome in a patient with systemic lupus erythematosus: a case report:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7585900/

Phenytoin-induced Stevens–Johnson syndrome with myocarditis: a rare case report:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5513850/

What drugs by mitochondria?
https://swaresearch.blogspot.com/2024/01/what-drugs-can-damage-mitochondria.html

Personal experience after mRNA vaccine  incl. images: 

Toxic Skin Condition Post-mRNA COVID-19 Vaccination:
https://swaresearch.blogspot.com/2024/06/stevens-johnson-syndrome-and-toxic.html












© 2025-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9  













































 

Comments

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

Dysferlin Protein: Key Roles, Genetic Locations